APA (7th ed.) Citation

T, R., F, B., P, S., J, S., M, V., D, B., . . . J, M. (2024). Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia. Therapeutics and clinical risk management, 20, 611. https://doi.org/10.2147/TCRM.S476187

Chicago Style (17th ed.) Citation

T, Romanová, et al. "Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia." Therapeutics and Clinical Risk Management 20 (2024): 611. https://doi.org/10.2147/TCRM.S476187.

MLA (9th ed.) Citation

T, Romanová, et al. "Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia." Therapeutics and Clinical Risk Management, vol. 20, 2024, p. 611, https://doi.org/10.2147/TCRM.S476187.